Carotid ultrasonography improves residual risk stratification in guidelines-defined high cardiovascular risk patients

Georgios Georgiopoulos1,2, Georgios Mavraganis1, Dimitrios Delialis1

  • 1Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens Medical School, 80 Vas. Sofias Str, Athens 11528, Greece.

Insights

Carotid atherosclerosis markers like maximal wall thickness improve risk prediction for cardiovascular events in high-risk patients. Specific thresholds can identify those needing further risk reduction or having a very low event probability.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Medical Imaging

Background:

  • Clinical value of carotid atherosclerosis markers for residual risk stratification in high atherosclerotic cardiovascular disease (ASCVD) risk patients is not established.
  • Current guidelines-defined risk stratification may not fully identify all patients requiring intensive management.

Purpose of the Study:

  • To derive and validate optimal values of carotid subclinical atherosclerosis markers for improving risk stratification in patients at high ASCVD risk.
  • To assess the incremental prognostic value of carotid intima-media thickness and plaque characteristics over clinical risk scores.

Main Methods:

  • Analysis of high or very high ASCVD risk patients from a CV prevention registry (n=751) and the ARIC study (n=2,897).
  • Assessment of intima-media thickness (maxWT, avg.maxWT) and carotid plaque presence.
  • Primary endpoint: composite of cardiac death, myocardial infarction, and revascularization.

Main Results:

  • Maximal wall thickness (MaxWT) > 2.00 mm and average maximal wall thickness (avg.maxWT) > 1.39 mm significantly improved risk reclassification (P < 0.05).
  • MaxWT < 0.9 mm predicted a very low probability of cardiovascular events (NPV = 97% and 92%).
  • Findings were confirmed for long-term events and across derivation and validation cohorts.

Conclusions:

  • Carotid ultrasonography markers provide incremental prognostic value beyond clinical risk scores.
  • Integration of carotid imaging can refine risk stratification, identifying very high-risk patients for intensified management or very low-risk individuals.
  • These markers aid in optimizing residual cardiovascular risk reduction strategies.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
137
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
79
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
48
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
44
Imaging Studies for Cardiovascular System I:Echocardiography01:17

Imaging Studies for Cardiovascular System I:Echocardiography

Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
496